Damora Therapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
DMRA Nasdaq 2836 www.damoratx.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Damora Therapeutics, Inc.

Damora Therapeutics (DMRA) Stock Looks Above Fair Value On Book Value - Oct 10th, 2026 8:21 am
Damora Therapeutics (DMRA) Climbed, So What Is Drawing Attention Now? - Oct 9th, 2026 11:10 pm
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Sep 3rd, 2026 6:00 am
Damora Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights - Aug 10th, 2026 2:05 pm
Damora Therapeutics Initiates Phase 1/1b CLARITY-101 Clinical Trial of DMR-001 in Patients with Mutant Calreticulin-Driven Essential Thrombocythemia and Myelofibrosis - Aug 5th, 2026 6:00 am
Damora Announces Redomestication from Delaware to Cayman Islands - Jul 17th, 2026 6:00 am
Why This Fund Made a $66 Million Bet on Damora Therapeutics Amid a 700% Surge - May 30th, 2026 12:12 pm
Damora Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights - May 12th, 2026 2:05 pm
What Damora Therapeutics (DMRA)'s CEO Shake-Up and Finance Refresh Means For Shareholders - May 8th, 2026 3:30 pm
Damora Therapeutics (DMRA) Appoints Jennifer Jarrett as President, Chief Executive Officer - May 5th, 2026 11:05 am
Assessing Damora Therapeutics (DMRA) Valuation After CFO Transition And Recent Share Price Momentum - May 5th, 2026 8:10 am
What Makes Galecto, Inc. (DMRA) a Strong Momentum Stock: Buy Now? - Apr 20th, 2026 10:00 am
How Much Upside is Left in DAMORA THERAPEU (DMRA)? Wall Street Analysts Think 73.1% - Apr 10th, 2026 7:55 am